Junction opener enables CAR T cell treatment of solid tumors
Abstract
Physical barriers presented by solid tumors limit CAR T cell efficacy. Thus, technologies to increase CAR T cell access to solid tumors could have massive implications in advancing CAR T cell therapies. Here we demonstrate that treatment of solid tumor-bearing mice with our Junction Opener technology and CAR T cells enhances tumor control - potentially enabling CAR T cell immunotherapy for solid tumors.
Fields of Study & Subjects
CAR-T cell therapy research
Cancer Immunotherapy and Biomarkers
Immunotherapy and Immune Responses
Publication details
- Journal / source
- Scientific Reports
- Volume
- 16
- Issue
- 1
- Publication date
- 7 March 2026
- Language
- EN